Cicada HealthTech Hub Masterclass: Dataroom Essentials for Investor Readiness in Healthtech & Lifescience Ventures
Description
Raising capital in health tech and life sciences is hard — the science might be world-class, but that's rarely enough. Investors need clarity and assurance before they commit, and one of the biggest sources of that assurance is your dataroom.
Founders and technical teams often underestimate what investors are actually looking for in a dataroom, and how much a well-structured one can accelerate — or a poorly structured one can stall — a funding round. This masterclass walks you through the frameworks, tools and real examples you need to build a dataroom that gives investors exactly what they need to say yes with confidence.
Whether you're preparing for your first raise or tightening up before your next one, you'll leave with a practical, investor-ready framework you can apply immediately.
This masterclass features a presentation on Dataroom essentials for Investor Readiness in Healthtech & Lifescience Ventures - providing innovators with a practical checklist and tools as your venture grow and scale, followed by a discussion with Dr Gisela Mautner (Principle, The Mautner Doc), Prashanth Rajan (Associate, Brandon Capital), Gordon Black (East West Capital) to discuss what works, what failed and what VCs, operators, Angels are looking for.
What you'll learn
How to structure your own dataroom — the basics, must-haves and good-to-haves
Tools for organising, storing, sharing and protecting your data
Dataroom alignment and protection — responsible use of AI tools, and where to be cautious
What investors are really looking for, and how to use your dataroom strategically
What should go into your investor memo
Common mistakes that slow down funding rounds — and how to avoid them
Who should attend
This session is designed for:
Start-ups and founders preparing for or currently in a capital raise
Researchers generating data for a potentially commercialisable product, particularly those from a strongly scientific/technical background who want to understand the investor lens
-----------
Don't miss this opportunity to gain valuable insights from industry experts and network with fellow health tech innovators.
Lineup
Andy Lamb (Entrepreneur, Facilitator)
Andy Lamb is a seasoned lean startup practitioner, entrepreneur, speaker and facilitator, and a thought leader in applying startup thinking and innovation-by-doing. He carries a broad range of experience across industries and business sizes. Previously founder and CEO of Atomic Sky, Andy has consulted for organisations including CSIRO, Bankwest, Cisco, UWA, Curtin University and the City of Perth.
Prashanth Rajan (Investment Analyst, Brandon Capital)
Prashanth is based in Brandon Capital's Sydney office, where he leads NSW activities. Before joining Brandon, he was Senior Commercialisation Manager at UniSA Ventures, the commercialisation and investment-management arm of the University of South Australia, where he led complex licensing transactions and managed a portfolio of IP. He has been part of several deal teams leading diligence, including investments into Pheon Therapeutics (Series A) and Advancell Isotopes. Prashanth holds a B.Technology in Bioinformatics from Sathyabama University (India), a PhD in Biochemistry and Molecular Biology, and an M.Biotech (Adv) from The University of Queensland.
Dr Gisela Mautner (Founder & Principal, The Mautner Docs)
Dr Mautner is an accomplished international business leader with over 30 years of experience in medical and scientific research. She has held senior leadership roles at global pharmaceutical companies including NoxoPharm, MSD, Bayer, Amgen and Siemens Medical Solutions, bridging deep medical expertise with corporate strategy across the launch of numerous drugs in diverse therapeutic areas. She holds an MD from the Technical University of Munich, a PhD from Ludwig-Maximilians-Universität, an MPH from Harvard, and an MBA from the Kellogg-WHU program. She also serves as a Non-Executive Director at Nyrada Inc.
Gordon Black (Founder & CEO, East West Capital)
Founder and Chief Executive Officer of a technology investment firm based in Sydney, Australia. East West invests globally in early-stage life sciences and emerging technologies companies. East West supports exceptional founders building solutions relevant to tackling the major challenges facing the world in the 21st Century.
Yan Lin Lye (Director of Business Development & Commercialisation, IDE Group)
A global citizen, Yan Lin has studied and worked in the US, UK, Singapore and Australia. Originally graduating at the top of her biomedical engineering class at the University of Southern California, she quickly found a passion for commercialising medical technology. Her pursuits since then have been focused on building the knowledge and experience to help entrepreneurs translate their ideas into reality. She has mentored over 100 start ups and helped dozens of companies on their product development journey. In her free time, she can be found at the pottery studio and out on hikes.
FAQs
- What is the Cicada HealthTech Hub?
Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.
Find out more about the Cicada HealthTech Hub
The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity
